Exenatide
Breaking New Ground: Exenatide, a GLP-1 Receptor Agonist, Emerges as a Promising Therapy for Idiopathic Intracranial Hypertension Idiopathic intracranial hypertension (IIH), a rare neurological disorder marked by elevated intracranial pressure (ICP) of unknown origin, disproportionately affects young women with obesity. Its hallmark symptoms—blinding headaches, vision loss, tinnitus, and cognitive impairment—significantly impair quality of life. With…